Qualitative Study on Osteoporosis Representation and Management in the General Population and in General Practitioners.

NCT ID: NCT02861989

Last Updated: 2016-08-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

114 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-02-28

Study Completion Date

2017-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Osteoporosis (OP) and subsequent fractures (OP fractures) are a source of morbidity and high mortality in the elderly. Despite numerous programs aiming at improving OP care, the prevention, diagnostic and treatment remain suboptimal. Barriers to a better care are multiple, both in the general and at-risk population, and in medical practitioners. Since they do not perceive their susceptibility to OP, people do not see the benefit of prevention. In addition, physicians do not give sufficient importance to OP prevention and care, despite the existence of guidelines.

The investigators implemented a qualitative study to explore the knowledge and representations regarding osteoporosis in the general and at-risk population and in doctors in Rhône-Alpes Region, France, using focus groups with women and men and semi-structured face-to-face interviews with general practitioners. Understanding barriers to osteoporosis care in patients and general practitioners will help to set up effective strategies to improve prevention and treatment.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoporosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Osteoporotic women

women over 50 years with a diagnosis of osteoporosis or history of fragility fracture /osteoporosis treatment

qualitative study

Intervention Type OTHER

At risk women

women over 50 years without a diagnosis of osteoporosis or history of fragility fracture /osteoporosis treatment

qualitative study

Intervention Type OTHER

Osteoporotic men

Men over 60 years with a diagnosis of osteoporosis or history of fragility fracture /osteoporosis treatment

qualitative study

Intervention Type OTHER

At-risk men

Men over 60 years without a diagnosis of osteoporosis or history of fragility fracture /osteoporosis treatment

qualitative study

Intervention Type OTHER

General practitioners

General practitioners from the Rhône area, France

qualitative study

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

qualitative study

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* group 1: women aged 50 to 85 years with a history of fragility fracture or an osteoporosis diagnostic
* group 2: women aged 50 to 85 years without a history of fragility fracture or an osteoporosis diagnostic
* group 3: men aged 60 to 85 years with a history of fragility fracture or an osteoporosis diagnostic
* group 4: men aged 60 to 85 years without a history of fragility fracture or an osteoporosis diagnostic
* group 5: general practitioners in Region Rhône-Alpes, France
* who signed the consent form

Exclusion Criteria

* no signed consent
* legal disability
* difficulty in understanding French
* psychiatric disorder
Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anne-Marie Schott, Pr

Role: PRINCIPAL_INVESTIGATOR

Hospices Civils de Lyon

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pôle IMER, Hospices Civils de Lyon

Lyon, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

69HCL16_0499

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.